APA

Mourelatos D., Kourakis A., Koliouskas D. E., Hatzitheodoridou P. & Dozi-Vassiliades J. (19870401). Enhancement of cytogenetic damage by inhibitors of poly(ADP-ribose)polymerase in human lymphocytes exposed to antineoplastics in vivo and in vitro. : Teratogenesis, carcinogenesis, and mutagenesis.

Chicago

Mourelatos D, Kourakis A, Koliouskas D E, Hatzitheodoridou P and Dozi-Vassiliades J. 19870401. Enhancement of cytogenetic damage by inhibitors of poly(ADP-ribose)polymerase in human lymphocytes exposed to antineoplastics in vivo and in vitro. : Teratogenesis, carcinogenesis, and mutagenesis.

Harvard

Mourelatos D., Kourakis A., Koliouskas D. E., Hatzitheodoridou P. and Dozi-Vassiliades J. (19870401). Enhancement of cytogenetic damage by inhibitors of poly(ADP-ribose)polymerase in human lymphocytes exposed to antineoplastics in vivo and in vitro. : Teratogenesis, carcinogenesis, and mutagenesis.

MLA

Mourelatos D, Kourakis A, Koliouskas D E, Hatzitheodoridou P and Dozi-Vassiliades J. Enhancement of cytogenetic damage by inhibitors of poly(ADP-ribose)polymerase in human lymphocytes exposed to antineoplastics in vivo and in vitro. : Teratogenesis, carcinogenesis, and mutagenesis. 19870401.